Page 502 - Textbook of Pathology, 6th Edition
P. 502

486
























           Figure 17.24  Microscopic appearance of a dilated distal bronchiole in bronchiectasis. The bronchial wall is thickened and infiltrated by acute
           and chronic inflammatory cells. The mucosa is sloughed off at places with exudate of muco-pus in the lumen (arrow).



           CLINICAL FEATURES.  The clinical manifestations of  3. Severe obesity
           bronchiectasis typically consist of chronic cough with foul-  4. Pleural diseases.
           smelling sputum production, haemoptysis and recurrent  As a group, these conditions cause restriction to
           pneumonia. Sinusitis is a common accompaniment of diffuse  expansion of lungs due to alterations in chest wall, pleura
           bronchiectasis. Late complications occurring in cases  and neuromuscular apparatus, but are primarily not lung
           uncontrolled for years include development of clubbing of  parenchymal diseases.
           the fingers, metastatic abscesses (often to the brain),  B. Restriction due to interstitial and infiltrative diseases.
           amyloidosis and cor pulmonale.
     SECTION III
                                                               Commonly called as ‘interstitial lung diseases (ILDs)’, these
                                                               are diseases characterised by non-infectious diffuse
           CHRONIC RESTRICTIVE PULMONARY DISEASE               parenchymal involvement of the lung i.e. the alveolar lumina
                                                               and alveolar epithelium, capillary basement membrane, the
           The second large group of diffuse lung disease is ‘chronic  intervening space, perivascular tissue and lymphatic tissue.
           restrictive pulmonary disease’ characterised by reduced  Diffuse lung parenchymal involvement may be primary, or
           expansion of lung parenchyma with decreased total lung  it may be involved secondarily as a part of some other multi-
           capacity. This group of diseases must be distinguished from  organ disease process. The term ‘infiltrative’ is used here to
           the foregoing COPD (Table 17.7).                    denote the radiologic appearance of lungs in chest
              Restrictive lung disease includes 2 types of conditions:  radiographs which show characteristic diffuse interstitial
           A. Restriction due to chest wall disorder:  It includes  ground-glass opacities. The ILDs consist of more than 200
     Systemic Pathology
           following conditions:                               heterogeneous conditions which have common clinical,
           1. Kyphoscoliosis                                   radiologic, and functional manifestations but diverse
           2. Poliomyelitis                                    pathological features. As a group, ILDs have high mortality


             TABLE 17.7: Obstructive versus Restrictive Pulmonary Diseases.
              Feature         Obstructive                      Restrictive
           1. Airways         Obstructed at any level from     Reduced expansion of lung parenchyma
                              trachea to respiratory bronchiole
           2. Pulmonary       Increased pulmonary resistance and  Decreased total lung capacity
              function test   obstruction of maximal expiratory airflow
           3. X-ray chest     Variable appearance depending    Typically bilateral infiltrates giving ground-glass
                              upon the cause                   shadows
           4. Examples        • Chronic bronchitis             • Chest cage disorders (e.g. kyphoscoliosis, poliomyelitis, severe
                              • Emphysema                         obesity and pleural disease)
                              • Bronchial asthma               • Interstitial lung diseases (ILDs) (e.g. pneumoconioses,
                              • Bronchiectasis                   idiopathic pulmonary fibrosis, immunologic lung diseases,
                                                                 collagen-vascular disease and sarcoidosis)
   497   498   499   500   501   502   503   504   505   506   507